Understanding the supply-chain challenge and coupling high-efficiency chromatographic techniques with information-rich detectors are leading to improvements in the management of extractables and leachables in parenteral drugs.

Amgen, Servier collaborate ivabraline and other cardiovascular products.

EMD Millipore and PharmaCell have entered into a collaboration to develop optimized large-scale expansion and harvest of HepaRG cells using bioreactor technology.

Marken's expansion is fully operational to support clinical-trial material supply.

A simple, rapid analytical method for the determination of palladium in pharmaceutical production samples will speed up development and optimization of reactions involving palladium catalysts.

Synthesis of tetracycline derivatives with novel substituents has been challenging. Using an approach based on a Michael-Dieckmann reaction, new compounds with enhanced antibiotic properties are now being prepared on a large scale.

Jubilant HollisterStier added an ampul filling line utilizing a rigid barrier system.

Till, a PhRMA vice president, will lead AAPS starting in November; Executive Council and Section leadership positions were also announced.

The expansion adds commercial specialty ligand, capacity manufacturing.

The companies sign a nonexclusive research license agreement, giving Sorrento's access to Lonza's GS Xceed Gene Expression System.

ScinoPharm Changshu Pharmaceuticals and Sundia MediTech form an alliance for contract research and manufacturing services in mainland China.

Gallus Biopharmaceuticals has signed a development and manufacturing supply agreement with Genzyme.

Sanofi Chimie will supply the API avanafil for VIVUS.

The companies initially focused on five biosimilar products.

Lyophilization Services of New England (LSNE) received a Certificate of GMP Compliance for its New Hampshire facility.

Adamis Pharmaceuticals agrees to license and potentially acquire 3M's Taper Dry Powder Inhaler technology.

The guidance describes a risk-based approach to monitoring of clinical trials.

A new study reveals how a promising anticancer specifically kills prostate cancer cells by compromising their ability to withstand environmental stress.

Donaldson Company, Inc. announced a $10 million expansion of its testing laboratories at its Bloomington, Minn., corporate headquarters.

Advanced Clinical announced the appointment of Cheryle Evans as vice president, Clinical Operations.

America's biopharmaceutical research companies are developing 444 new medicines to prevent and treat neurological disorders, according to a new report released by PhRMA.

Singapore facility delivers manufacturing redundancy and increases supply assurance for global biologic drug discovery and production.

Weill Cornell scientists reveal how a protein drug eradicated human lymphoma in mice.

Edwards will oversee company's financial, logistical and human-resources operations.

Funding awarded to develop innovative solutions that address unmet health needs.

Additional investment from the Biomedical Catalyst will fund multiple programs in the UK.

Selected trendsetters reflect changes in the pharmaceutical industry.

Survey confirms strong link between choice of preferred central laboratory and investigator satisfaction with study sponsors.